TARRIFF SCOTT (CEO) reported 1 transaction at EAGLE PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/9/2024ACC: 0000950170-24-003397
DirectorOfficer· CEO
Since Jun 2018
-4.32K
Net shares
Net seller
$22.2K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
4.32K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−4.32K
Price / share
$5.13
Trade value
$22.17K
% of position
0.8%
1/5/2024
545.45K→541.13K
Total
Net shares
−4.32K
Net value
-$22.17K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2024 | F · Tax Withholding | −4.32K | $5.13 | $22.17K | 0.8% | 545.45K | 541.13K |
| Total | −4.32K | -$22.17K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned992.62K
Total
992.62K indirect992.62K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 992.62K | Indirect |
| Total | 992.62K | 992.62K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported